Citation 6454

SABAREESH,V: RANGANAYAKI,RS: RAGHOTHAMA,S: BOPANNA,MP: BALARAM,H: SRINIVASAN,MC: BALARAM,P:. (2007). IDENTIFICATION AND CHARACTERIZATION OF A LIBRARY OF MICROHETEROGENEOUS CYCLOHEXADEPSIPEPTIDES FROM THE FUNGUS ISARIA. 70(5)

Citation Details

TitleIDENTIFICATION AND CHARACTERIZATION OF A LIBRARY OF MICROHETEROGENEOUS CYCLOHEXADEPSIPEPTIDES FROM THE FUNGUS ISARIA
AuthorsSABAREESH,V: RANGANAYAKI,RS: RAGHOTHAMA,S: BOPANNA,MP: BALARAM,H: SRINIVASAN,MC: BALARAM,P:
Year2007
Volume70
Issue5

Summary

Year: 2007

Journal: Unknown

Organisms and Their Experiments (1)

Isaria species (HYPHOMYCETES)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MS
ISARIIN A
None
2Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MS
ISARIIN B
None
3Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MS
ISARIIN C
None
4Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MS
ISARIIN D
None
6
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ISARIIN A
INACTIVE
7
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ISARIIN B
INACTIVE
8
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ISARIIN C
WEAK ACTIVITY
9Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MSIDENTIFICATION OF A COMPOUND WITH NOVEL STRUCTURE
ISARIIN C2
None
10Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MSIDENTIFICATION OF A COMPOUND WITH NOVEL STRUCTURE
ISARIIN E
None
11Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MSIDENTIFICATION OF A COMPOUND WITH NOVEL STRUCTURE
ISARIIN F1
None
12Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MSIDENTIFICATION OF A COMPOUND WITH NOVEL STRUCTURE
ISARIIN F2
None
13Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MSIDENTIFICATION OF A COMPOUND WITH NOVEL STRUCTURE
ISARIIN G1
None
14Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MSIDENTIFICATION OF A COMPOUND WITH NOVEL STRUCTURE
ISARIIN G2
None
15Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MSIDENTIFICATION OF A COMPOUND WITH NOVEL STRUCTURE
ISARIDIN C1
None
16Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MSIDENTIFICATION OF A COMPOUND WITH NOVEL STRUCTURE
ISARIDIN C2
None
17Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MSIDENTIFICATION OF A COMPOUND WITH NOVEL STRUCTURE
ISARIDIN D
None
18Not specified
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLC/MSIDENTIFICATION OF A COMPOUND WITH NOVEL STRUCTURE
ISARIDIN E
None
Show SPARQL Queries (1)